Acetylcysteine/Pentoxifylline

乙酰半胱氨酸/己酮可可碱

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAcetylcysteine/Pentoxifylline

Drug Alias NameAcetylcysteine+OxpentifyllinePentoxifylline/AcetylcysteinePentoxifylline+AcetylcysteineOxpentifylline/AcetylcysteineOxpentifylline+Acetylcysteine +[8]

ClassificationSmall molecules

Mechanisms of ActionFree radicals inhibitorsPhosphoric diester hydrolases inhibitors

TargetsFree radicalsPhosphoric diester hydrolases

Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes Acetylcysteine Pentoxifylline

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesIntelgenx Corp Ra Chem Pharma

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesRa Chem Pharma Pacific Therapeutics Ltd Intelgenx Corp

Active IndicationsN/A

Inactive IndicationsIdiopathic Pulmonary Fibrosis

Other Information

ATC CodeN/A